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Proteinasc yscE, the prouusomrlmulti~t~lytic-rnullirunctioll~) protrim~sc 01’ ycust had been shown to fun&on in stress response and in the 
degradation of ubiquitinmed proteins I(1991) EMBO J, IO, 555-562]. A wcll.dcRncd SCL of proteins dcgritded via ubiquitin-mcdiuled proteolYsis 
are the substriltes or the N-end rule pathway [( 1986) Scicncc 234. 179-186; ( 1989) Science 243, 1576-15831, WC show that mutanls dercclivc in the 
chymorryptic ktivity of proteinasc yscE fail to degrade subsiratcs of’ the N-end rule p~Itb\+~ily, This gives further prool’of the proteusome being 
u central cutalyst in ubiquitin-medintcd protsolysis. 
Proteinasc yscE; Proteasomc/multicutalytic-multifunctional proteinasc: Ubiquitin; N-end rule; Proteolysis; Yeast 
1. INTRODUCTION 
The proteasome/multicatalytic-multifunctional pro- 
teinase belongs to a class of protein complexes, which 
can be found in all eukaryotic ells and which has been 
conserved during evolution from yeast to man [l-7]. 
The protein particle of about 700 kDa mass consisting 
of at least 12 different subunits in the molecular mass 
range of between 20 and 38 kDa has been extensively 
studied in vitro (for reviews, see [6,7]), hut until recently 
[S] no in vivo function could be assigned to the protein 
complex. Speculative functions for the particle ranged 
from controlling mRNA-activity [9] to protein matura- 
tion and degradation (for reviews, see [6,7]). Three pro- 
teolytic activities could be assigned to the proteasome. 
These activities have been called ‘chymotrypsin-like’. 
‘trypsin-like’ and ‘pcptidylglutamyl-peptide hydrolyz- 
ing’ activit:! (for reviews, see [6,7]). The yeast Srrr&~o- 
n?ycrs rrrevisiue has turned out to be an excellent model 
organism to study eukaryotic ell function as this or- 
ganism is easily accessible to biochemical, genetic and 
molecular biological manipulation. As such, yeast has 
given central insights into the function of protcolysis in 
eukaryotic cells (for reviews, see [lo-131). We had de- 
tected, purified and characterized the yeast proteasome/ 
multicatalytic-multifu;;ctional proteinase, which we 
had named proteinase yscE [14]. Mutations in the chy- 
motryptic activity of proteinase yscE had for the first 
Cwr&on&nce ~rfhss: D.H. Wolf, Institut fur Biochcmie, Universi- 
tat Stuttgart, Pkffenwaldring 55, D-7000Sruugnrt 80,Gcrmany. Fax: 
(49) (71 I) 685 4392 
time given in vivo evidence that the proteasome is in- 
volved in intracellular protein degradation and stress 
response [8]. One degradation pathway which is severely 
affected by a defective chymotryptic activity of pro- 
teinasc yscE is ubiquitin-mediated proteolysis. as the 
bulk of ubiquirinated proteins accumulate intracellu- 
larly in proteinase yscE mutant cells [S]. Specific sub- 
strates, which are known to be degraded via ubiquitin- 
mediated proteolysis consist of substrates of the N-end 
rule pathway [I 5-181, Slere we show that the yeast pro- 
zasome is linked to degradation of substrates of the 
N-end rule pathway. 
2. MATERIALS AND METHODS 
The inhibitors pepstotin A. chymostatin, antipain, leupeptin and 
aprotinin !vcrc obtained from the Pcptide Institute (Osaka, Japan). 
The monoclonal antibodies recognizing P-galactosidase were pur- 
cltuscd rronj Bochringer Mannheim (Mannheirn, Germany) and 
Promcgil (Hcidclbcrg, Germany). [L5S]mcthioninc was obtained from 
Amcrsham (Brounschwcig, Germany), Yeust nitrogen base without 
amino acids wus purchased Tram Dil’co (Detroit, USA). All other 
chemictils were obtained from Phtirmtlcia (Freiburg, Gcrmnny), Roth 
(Karlsruhc, Germany). Merck (Darmstadt, Ciermarly) and Scrva (Hei- 
delberg, Germany). 
YPD medium (2% glucose, 1% yeast extrxt, 296 peptonc) and 
complete minimal [CM) dropout medium were prepared according to 
Ausubcl et al. [19]. CM dropout medium contained 0.67% yetlst nitro- 
gcn busu withtiut amino acids and 246 gulactosc supplemented with 
adcninc und amino acids. The r%]methionine labeling medium used, 
consisted oTCM dropout medium without urticil and merhioninc. 
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2.3. Struitts 
Yeat strains used wcw: BRl (M.4Tu urrr3 l1is3-If,15 GAL’): BR2 
(MAru preJ-J uru3 GAL’); BR3 (MATu pre2.l uru3 iti&ll,f5 
k1&3.112 GAL*); BR4 (MATa prel-l pt?2-2 urrr3 hb3-JJ,J5 
/cu2-3.f 12 GAL*) 
Strains BRl and BR2 were obtained by mating strain 95/2-3D/l5D 
(MAT&/ml-l uruj-5 his3-J!.J5ku2-3, II?) with strain L3906(MATu 
trpl-1 rrru3-5.! GAL’) followed by isolation of diploids and sub- 
sequent sporuladon. 
Strain BR3 was obtained by mating strain Il9/3_9D (MATaprR-2 
uru3.5 his3. f 1.15 (d-3,112) with strain L3906 l’ollowcd by isolation 
of diploids and subsequent sporulation. 
Similarly strain SR4 was obtained from a cross of strain BR2 with 
strain 1]9/3-91). E, cuiisrrain MC 1061 was used as host of plasmids. 
Isolation, purifcation and analysis of DNA wcrc carried out ac- 
cording to standard procedures 1201. For trunsformntion a protocol 
modified according to [S] was followed. The yeast strains were trans. 
formed with the 2p-bused plasmids pU I323 expressing ubiquitin-X-p- 
gdlactosidasc fusion proteins under control ofthc gahictosc inducible 
GALJ promotor [lS,lS]. 
Labeling of&s, preparation oTccll extracts. immunoprccipitation 
of J-Salactosidase antigcnic materiul, SDS-PAGE und Ruorography 
were csscntially done as described by Bartcl cl al. [2l]. Prior to label- 
ing.cclls were grown 24 h 1;t 3OT in CM medium. After ccnlrifugalion 
cells were diluud into fresh CM medium yielding a11 Ol& “,,, of 0.5 
and incubated for 3 h at 30°C SDS-PAGE was done in a 7.5% gel. 
lmmunoblotting was donc according to Towbin ct al. [22J. 
Wild type and mutant strains carrying the respective ubiquitin-X-P 
galactosidusc expressing plasmid were grown in CM dropout medium 
containing 2% gdlactose for 24 h ut 30°C. Cells wcrc harvested by 
ccntrifu@on and extracts were prepared in Eppendorf tubes using 
glass beads [8]. The buffer was 0.1 M potassium phosphate pM 7.0 
containing chymoatatin (20p@ml), pepstutin (20/@ml) and 4-hydro- 
xymcrcuribenzoate (5 mM). Enzymatic activhy ora-galaetosidase in 
crude eXtraets wus medsurcd using oenitro-phenyl-8.n-yalaetosidc. as 
outlined in [l9]. The amount orprotein was detcrmincd by the method 
of Lowry ct al. [23]. 
3. RESULTS 
We had isolated mutants defective in the chymotryp- 
tic activity of proteinase yscE. The mutants fell into two 
complementation groups peel and pre2 [8]. The wild- 
type genes (PREl and PRE2) were isolated and se- 
quenced and shown to encode subunits of proteinase 
yscE of 22.6 kDa and 31.6 kDa, respectively [8,24]. 
Mutations in either of the two subunits of the enzyme 
resulted in a defective stress response and led to an 
accumulation of ubiquitinated proteins [8,24]. Deletion 
of either of the two subunits leads to cell death [8,24]. 
To test the function of proteinase yscE in distinct 
proteolytic pathways known to be dependent on ubiq- 
uitin, we chose the N-end rule pathway. Using well- 
defined engineered fusion proteins it :vas uncovered 
that the amino terminus of the fusion protein acts as a 
primary signal determining its half-life [IS]. As a sec- 
ondary signal for degradation to occur the posttransla- 
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Fig. 1. Steady-state levels of X-B&al test proteins in wild-type and 
mutant cells detcctivc in chymotryptic activity of protcinasc yscE. 
Cells wcrc grown and disintegrated as indiated in Section 2. (A) 
Wild-type BRI, lanes 1,3,5,7,9,11; prl*J-J mutant BR?. lanes 
2.4,6.8,10.12, (B) Wild-type BRI. ktflt?a l.3.5,7.9.1 I; pre?--2 mutant 
BR3. lanes 2.4.6.8.10.12. (C) Wild-type BRI. lanes 1,3.5.7,9.1 l:pref-J 
ptd-2 double muianl BR4.lancs2,4.6.8.10.12. X-&al proteins tcstcd: 
Arg-@gal, lanes I and 2: Leu-&+I. laaes 3 and 4: Tyr&al. lanes 5 and 
6; Lib-Pro-&l. lanes 7 and 8; Ser-&al, lanes 9 and IO: Ala-pgal. lanes 
1 I and 12; lane 13. fi-gul. Molceular mass markers were: O+UC- 
roglobulin. hf, = I80 kDu: &galactosidasc. M, = I 16 kDa; herosc- 
6phospharc kinasc. IVY = 84 kDa: pyruvatc kinasc. M, = 58 kDa; 
Tumurasc. Mr = 48.5 kDa. 
tein is necessary [17,18]. The engineered proteins used 
were ubiquitin-X-&galactosidase fusion proteins (Ub- 
X-&al), where ‘X’ stands for any amino acid residue. 
In the yeast cell, ubiquitin C-terminal hydrolases rap 
idly remove ubiquitin from the fusion protein, exposing 
the amino terminal residue l X’ of the remaining part of 
the protein [I 51. An exception is ubiquitin-proline-fl- 
galactosidase (Ub-Pro-jIgal), which is only very slowly 
cleaved by the hydrolase i 151. j-galactosidase proteins 
carrying N-terminal amino acids which destine the pro- 
tcin to rapid degradation lA . . ,..rg, Leu. Tyr) undergo at- 
tachment of a multiubiquitin chain onto a specific lysine 
residue of the substrate [ 15.17, IS]. This ubiquitination 
reaction is dependent on the substrate recognition pro- 
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kin Ubrl (21) and the Ubc2 ubiquitin conjugating cn- 
zyme [25-271. Ub-X-/3gal fusion proteins which arc not 
deubiquitinated because of the nature of ‘X’ (proline) 
are short-lived and undergo a multi-ubiquitination reac- 
tion at Lys” of the N-terminal ubiquitin [181. This reac- 
tion is dependent on the ubiquitin conjugating enzymes 
Ubc4 and Ubc5 [IQ 
To test the involvement of proteinase yscE in the 
ubiquitin-dependent N-end rule pathway we analyzed 
the stability of short-lived /3-galactosidase fusion pro- 
teins in prci-I (Table 1. Fig. 1) and ~~2-2 (Table I, Figs. 
1 and 3) mutant cells as well as in double mutants 
(prei-l pre2-21 (Table 1, Figs. I and 3) defective in both 
subunits of proteinase yscE, which in their intact form 
confer the chymotryptic activity to the enzyme, Both 
mutationsconsist ofan amino acid exchange ach in the 
respective subunit: prel-f leads to a change of Ser”? to 
Phe’“, pre2-2 to a change of AlalZJ to Val”’ [24]. 
Cells were transformed with the plasmids expressing 
the different engineered Ub-X-/?gal proteins. At first we 
measured /?-galactosidase (@gal) activities and the pro- 
lein levelsof Arg-j?gal (t,,p2 min), Leu-pgal (r,,:*3 min), 
Tyr-pgal (!,,2” IO min), Ub-Pro-/?gal (I,,,-7 min), Ser-&al 
and Ala-/3gal (f ,,? 3 20 h) [15] in extracts of wild-type 
and mutant cells. These measurements were expected to 
result in steady-state activity and protein levels of the 
metabolically differently stable proteins, As can be seen 
from Table I only very low specific pgal activities can 
be found in wild-type cells of the metabolically highly 
unstable fusion proteins Arg-pgal, Leu-/Igal, Tyr-/Igal 
ond Ub-Pro;Bgal while considerably higher activities 
are found for the metabolically stable fusion proteins 
Ser-/?gal and Ala-bgal. In the proteinase yscE mutants 
carrying either the prel-f or the pre2-2 mutation or 
being defective in both subunits (prel-1, pre2-2) consid- 
erably higherpgal activities were found for the metabol- 
ically unstable fusion proteins LIS compared to wild-type 
(Table I). Increase ofpgal activity in peel-1 mutant cells 




Fig. 2. Purified S_galactosidasc competes with a distinct protein band 
of Ala-&al-expressing cells. Strain BR3, transformed with the Ala- 
/3gal expressing plasmid. was grown, labeled with [J5S]methionine for 
3 min and disintigratcd as indicated in Section 2, Immuuoprecipita- 
tion, SDS-PAGE and fluorography were done as outlined in Section 
2. All steps were done as in experiments in Fig. 3. Lane 1, no addition; 
lanc 2, addition of 250 pg purified /&galactosidasc prior to im- 
munoprecipitation. 
tein) to three-fold for Ub-Pro-@gal, a less unstable pro- 
tein. In contrast, no significant alteration in /#gal activ- 
ity was found for the metabolically rather stable pro- 
teins Ser-pgal and Ala-pgal (Table I). Increase in /?gal 
activity as compared to wild-type of the metabolically 
unstable X$gal proteins was even somewhat higher in 
~~2-2 mutant cells and highest in prel-f pre2-2 double 
Table I 
BGalactosidasc activity of&al test proteins in wild-type @RI) and mutants (BR?. BR3. BR4) of yeast defective in the chymotryptic activity of 
protcinase YSCE 
@Gal Lest protein Specific activity 0TPgal test protein (U/mg) in strain 
BKI BR? BR3 BR4 
(wild type) (pref-I) (prd-2) (prei-I 0~2.2) 
Ratio Ratio Ratio 
A&gal 2.3 20.8 9 21.3 I I.9 31.1 13.6 
Lcu-&al 4 21 5.3 19.2 4.8 35.6 8.9 
Tyr-bgal 9.6 36. I 3.8 51.2 60 6.3 
U b-Pro$?gul 26 18 3 80.3 
:*: 
91,7 3.5 
Ser./!&al 67 91 1.4 !c?7 I:6 100 I.5 
Ala-&al 123 96 0.8 93.2 0.8 70 0.6 
Cell extrxts were prcparcd as outlined in Section 2, /3-Galactosiduse activity was meusurcd with o-nilrophcnyl-p-o-galacloside as outlined [l9]. 
‘Ratio’ dcsignatcs the ratio of the specific activities of the respective X+&al protein mcasurcd in mutanl extract and wi!d type cxtraci. 
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mutants (Table 1). Also here no significant alterations 
in activity were found for the metabolically rather stable 
X-Bgal fusion proteins carrying Ser or Ala at the amino= 
terminus (Table I). The apparently lower activity level 
of Ala-bgal in the pre mutant cells tested cannot be 
explained at present. It may reflect a different plasmid 
copy number or expression of the plasmid-encoded pro- 
tein in wild-type and mutant cells under the conditions 
tested. Alternatively degradstion of this protein by 
some other proteolytic system may be enhanced in the 
mutant cells deficient in the chymotrypsin-like activity 
of the proteasome. The increased steady-state activity 
levels measured of the metabolically unstable X-&+a1 
proteins in proteinase yscE mutant cells as compared to 
wild-type is reflected by their protein ievels eparated on 
SDS-PAGE and detected by immunoblotting (Fig. 1, 
see mark). While for instance very little/?-gal protein of 
the highly unstable Arg-@gal, Leu$gal, Tyr-Bgal or Ub- 
Pro-/?gal can be detected immunologically in wild-type 
cells (Fig. I A,B,C lanes I ,3,5,7), its content is consider- 
abfy increased in all proteinasc yscE mutant cells (Fig. 
1 A,B,C lanes 2,4,6,8), Here it reaches nearly the amount 
of bgal protein found for the most stable constructs in 
wild-type cells, Ser-&al and Ala-~gal (Fig. lA,B,C 
Ianes 9 and 11). These results indicated that the 
metaboIi~~lly unstable test-proteins Arg-@gal, Leu- 
pgal, Tyr-bgal and Ub-Pro#gal (Fig. lA,B,C lanes l-8) 
were stabilized In proteinase yscE mutants defective in 
the chymotryptic activity of the enzyme. 
To gain final proof of the proteolytic stabilization of 
the metabolically unstable X#gal proteins we detcr- 
mined their degradation rates by conducting pulse- 
chase experiments. Wild-type and mutant cells were 
briefly labeled with fJ%jmethionine, and ceI1 lysates 
were subjected to immulloprecipitation using antibodies 
specific for PgaI. Labeled and precipitated protein was 
separated by SDS-PAGE. Puri~ed ~-~~lactosidase spc- 
cifically competed with the labeled uppermost protein 
band of Ala-/?gaI expressing cells, indicating this upper- 
most protein to be @-galactosidase antigenic material 
(Fig, 2, compare lanes 1 and 2). Comparison of cells 
which do or do not express plasmid-encoded p-galacto- 
sidase shows that the uppermost protein band is indeed 
,&galactosidase protein (not shown). We thus compared 
the fate of this antigenic protein in proteinase yscE wild- 
type strain BRl and mutant cells (strains BR3 @re2-2) 
and BR4 @&-I pre2-2)) (Fig. 3). As shown previously 
1153, the metaboli~IIy stable test protein Ala-~~~l re- 
mained stable in wild-type cells during the test period 
(30 min) (Fig. 30, lanes l-3) whereas proteins known 
to be metabolically unstable in wild-type cells as are 
Arg-pgal, Leu-&al and Ub-Pro-&al [ 153 disappeared 
rapidly with time (Fig. 3A, B, C, lanes I to 3). In con- 
trast pro?einase yscE mutant cells RR3 @r&2) or BR4 
(prei-I prR-2) led to complete stabilization of these in 
wild-type unstable test proteins (Fig. 3A, B, C, Ianes 4 
to 9). 
wt.t tym a&2&2 
1 a 3 4 5 6 7 8 3 
Fig. 3. gradation of X-#&al test proteins in wild typ and mutant 
ceils defective in the chymotryptic activity of proteinase yscE. Ceils 
were grown, labeled with f’$]mcthionine and disintigrated as indi- 
cated in Scclion 2. Immunopncipitation, SDS-PAGE and fluorogm- 
phy were done as outlined in Section 2. Labeling was done for 3 min 
(time point 0 (lanes 1,4 and 7)) and thereafter cells were chased with 
non-radioactive methioninc (10 mM) for 10 min (lanes 2.5 and 8) and 
30 min (lanes 3, 6 and 9). ‘I&t proteins used were: Arg-/?gal (A), 
Leu;Bgal (5). Ub-Pro&al (C!) and Ala-@gal (D). Degradation of test 
proteins in wild-type cells #RI) lanes 1,2,3; degradation i  pre2-2 
mumnt cells (RRf) lanes 4,5,6; degradation i  Irrel-I. prcZ-2 double 
mutant c&s (DR4) lanes 7,8,9. Variation in band intensities of wild 
type and n~utant cells at time-point zero iire due to djfferent exposure 
times of ~1s ori~i~ting from inde~ndent e%~riment5, 
4. DISCUSSION 
WC have shown that mutations in subunits of pro- 
teinase yscE conferring chymotryptic activity result in 
metabolic stabilization of othetiise unstable proteins 
degraded via the N-end rule pathway. Mutations in the 
P&El or in the PRE2 gene show several-fold increased 
activities (Table I) and protein levels (Fig. 1) of Arg- 
flgal, Leu-&al, Tyr-&al and U~Pro-~gal as compared 
to wiId-type. Combination of the two mu~tions prd-I 
and pre2-2 Ieads to sn even tighter phenotype, The 
metabolically unstable /Igal proteins are more enriched 
in activity and protein over wild-type than in the single 
mutants (Table I, Fig. 1). Degradation rates of the 
metabolically unstable@gal proteins were directly tested 
in a single mutant @I’&.?) and the double mutant (pref-l 
pre2-2) defective in both subunits necessary for chy- 
motryptic activity of the enzyme. Clearly, degradation 
of the in wild-type highly unstable Arg-pgal, Leu-&al 
and Ub-Pro-@gal proteins is dramatically reduced in the 
mutant strains. They appear to be stable during the time 
tested (Fig. 3A,B,C lanes 4-9). We tested the stability 
of metabolically unstable pgal proteins also in strain 
BR2 carrying the p&-I point mutation. As expected, 
the engineered proteins were completely stabilized (not 
shown). The Arg-figal-, Leu-peal- and Tyr-Bgal pro- 
teins are ubiquitinated prior to degradation via the 
UK2 encoded ubiquitin-conjugating enzyme [25,26] 
whereas Ub-Pro-&al is further ubiquitinated via the 
UBCV-UBCS encoded ubiquitin-conjugating enzymes 
[IS] prior to degradation. Thus, our experiments 
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strongly suggest that proteinase $cE 
occur [28], The capacity of proteinase yscE to mediate 
degradation of ubiquitinated proteins derived from dif- 
ferent pathwajrs may suggest that the protea~o~e r pre- 
sellts the final target for degradation of ubiquitinuted 
proteins in general and thus also of ubiquitinated cyclin. 
Indeed. the lethality of null mutations in different sub- 
units of proteinase yscE [8,24,29-3 11 of cells would sup- 
port such a central function for the proteasome. 
A general involvement of proteinase yscE in ubiq- 
uitinmmediated proteolysis would also predict the short- 
lived Mata transcriptional regulator of matins type in 
yeast cells, which undergoes ubiquitination 1321, to be 
a substrate of proteinase yscE. 
Even though the degradation of the engineered test 
proteins was blocked in the proteinase yscE mutants 
defective in the chymotryptic activity, the proteins accu- 
mulating did not show the pattern of multiply ubiquiti- 
nated proteins. This observation is unexpected as the 
bulk of proteins accumulating in proteinase yscE mu- 
tants with chymotryptic deficiency under stress condi- 
tions are ubiquitinated [8,243. An explanation for this 
pilenomeIlon might be that proteii~ase yscE has some 
function in the ubiquitin conjugation reaction of N-end 
rule substrates, which is defective in tlte mutants tested. 
Alternatively, N-end rule substrates which are not hy 
drolyzed by proteinase yscE are subject to rapid re- 
moval of the ubiquitin moieties by the ubiquitin C- 
terminal hydrolases. Also a limited cleavage step by one 
of the remaining activities in the mutant proteasome 
(the trypsin-like or peptidyl glutamyl-peptide hy- 
dro~i~in~ act~vity~ removing a short amino-terminal 
peptide chain containing the ubi~luitin moiety from the 
test proteins cannot be excluded. 
it is a challenging task for our future research to 
uncover the different proteolytic pathways the pro- 
teasome is involved in. and to correlate the different 
structural components of the enzyme complex - some 
of which are under heavy debate [33-353 - with their 
function in the degradation reactions. 
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